Evoke Wealth’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$276K	Buy	+4,890	New	+$285K	0.01%	565
2025 Q4	–	Sell	-5,093	Closed	-$276K	–	689
2025 Q3	$276K	Buy	5,093 +86	+2%	+$4.92K	0.01%	521
2025 Q2	$275K	Buy	+5,007	New	+$295K	0.01%	473
2022 Q4	–	Sell	-150	Closed	-$13K	–	463
2022 Q3	$13K	Hold	150	–	–	﹤0.01%	702
2022 Q2	$12K	Hold	150	–	–	﹤0.01%	739
2022 Q1	$12K	Sell	150 -1,921	-93%	-$161K	﹤0.01%	732
2021 Q4	$183K	Buy	2,071 +173	+9%	+$14.3K	0.01%	379
2021 Q3	$146K	Buy	1,898 +104	+6%	+$8.21K	0.01%	376
2021 Q2	$150K	Buy	1,794 +380	+27%	+$30.1K	0.01%	391
2021 Q1	$107K	Buy	1,414 +1,264	+843%	+$103K	﹤0.01%	367
2020 Q4	$13K	Hold	150	–	–	﹤0.01%	539
2020 Q3	$11K	Hold	150	–	–	﹤0.01%	540
2020 Q2	$19K	Sell	150 -120	-44%	-$11.9K	﹤0.01%	470
2020 Q1	$22.8K	Buy	+270	New	+$23.3K	﹤0.01%	423
2019 Q4	–	Sell	-170	Closed	-$11.5K	–	1273
2019 Q3	$11.5K	Buy	+170	New	+$13.1K	﹤0.01%	792